Cargando…
Regulation of Insulin Degrading Enzyme Activity by Obesity-Associated Factors and Pioglitazone in Liver of Diet-Induced Obese Mice
Insulin degrading enzyme (IDE) is a potential drug target in the treatment of type 2 diabetes (T2D). IDE controls circulating insulin through a degradation-dependent clearance mechanism in multiple tissues. However, there is not sufficient information about IDE regulation in obesity. In this study,...
Autores principales: | Wei, Xiuqing, Ke, Bilun, Zhao, Zhiyun, Ye, Xin, Gao, Zhanguo, Ye, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989328/ https://www.ncbi.nlm.nih.gov/pubmed/24740421 http://dx.doi.org/10.1371/journal.pone.0095399 |
Ejemplares similares
-
Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice
por: Merino, Beatriz, et al.
Publicado: (2020) -
Combination of Pioglitazone and Metformin Actions on Liver Lipid Metabolism in Obese Mice
por: Liu, Jieying, et al.
Publicado: (2023) -
Bile acid TUDCA improves insulin clearance by increasing the expression of insulin-degrading enzyme in the liver of obese mice
por: Vettorazzi, Jean Franciesco, et al.
Publicado: (2017) -
ATP reduces mitochondrial MECR protein in liver of diet-induced obese mice in mechanism of insulin resistance
por: Qian, Shengnan, et al.
Publicado: (2020) -
Effects of Pioglitazone on Insulin Sensitivity and Serum Lipids in Obese Cats
por: Clark, M., et al.
Publicado: (2013)